Is XRAY Stock Undervalued?
Dentsply Sirona (NASDAQ:XRAY) is a large manufacturer of dental equipment…
Sell
22
GMED Quote, Financials, Valuation and Earnings
Last price:
$60.14
Seasonality move
:
4.23%
Day range:
$61.05 - $61.61
52-week range:
$51.79 - $94.93
Dividend yield:
0%
P/E ratio:
23.80x
P/S ratio:
3.23x
P/B ratio:
1.93x
Volume:
864.4K
Avg. volume:
1.5M
1-year change:
-15.01%
Market cap:
$8.3B
Revenue:
$2.5B
EPS (TTM):
--
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $789M | $958.1M | $1B | $1.6B | $2.5B | |
| Revenue Growth (YoY) | 0.47% | 21.43% | 6.76% | 53.35% | 60.62% | |
| Cost of Revenues | $217.5M | $257.7M | $281.5M | $599.2M | $1.2B | |
| Gross Profit | $571.6M | $700.4M | $741.4M | $969.3M | $1.4B | |
| Gross Profit Margin | 72.44% | 73.1% | 72.48% | 61.8% | 54.16% | |
| R&D Expenses | $84.5M | $63M | $72.9M | $124M | $151.1M | |
| Selling, General & Admin | $354.8M | $408.1M | $432.1M | $643.4M | -- | |
| Other Inc / (Exp) | -$3.5M | -$23.7M | -$7.5M | -$56.6M | -$94.8M | |
| Operating Expenses | $456.1M | $471.2M | $505M | $767.4M | $1.1B | |
| Operating Income | $115.5M | $229.2M | $236.4M | $201.9M | $232.3M | |
| Net Interest Expenses | -- | -- | -- | -- | $4.2M | |
| EBT. Incl. Unusual Items | $125.9M | $180.4M | $243M | $165.4M | $120.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $23.6M | $31.2M | $52.9M | $42.5M | $17.7M | |
| Net Income to Company | $102.3M | $149.2M | $190.2M | $122.9M | $103M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $102.3M | $149.2M | $190.2M | $122.9M | $103M | |
| Basic EPS (Cont. Ops) | $1.04 | $1.48 | $1.89 | $1.09 | $0.76 | |
| Diluted EPS (Cont. Ops) | $1.01 | -- | -- | -- | -- | |
| Weighted Average Basic Share | $98.6M | $100.7M | $100.5M | $113.1M | $135.7M | |
| Weighted Average Diluted Share | $101M | $103.6M | $102.6M | $114.6M | $137.9M | |
| EBITDA | $178.3M | $299M | $304.7M | $346.6M | $486.3M | |
| EBIT | $115.5M | $229.2M | $236.4M | $201.9M | $232.3M | |
| Revenue (Reported) | $789M | $958.1M | $1B | $1.6B | $2.5B | |
| Operating Income (Reported) | $115.5M | $229.2M | $236.4M | $201.9M | $232.3M | |
| Operating Income (Adjusted) | $115.5M | $229.2M | $236.4M | $201.9M | $232.3M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $251M | $263.6M | $291.6M | $629.7M | $745.3M | |
| Revenue Growth (YoY) | 68.56% | 5.03% | 10.61% | 115.93% | 18.37% | |
| Cost of Revenues | $63.8M | $72.9M | $81M | $289.7M | $279M | |
| Gross Profit | $187.2M | $190.8M | $210.6M | $339.9M | $466.4M | |
| Gross Profit Margin | 74.57% | 72.36% | 72.22% | 53.99% | 62.57% | |
| R&D Expenses | $15.5M | $17.4M | $21.3M | $37.7M | $39.7M | |
| Selling, General & Admin | $107.3M | $106.7M | $120.1M | $238.1M | -- | |
| Other Inc / (Exp) | -$13.4M | $1.4M | -$2.8M | -$12.9M | $64.7M | |
| Operating Expenses | $127.4M | $124.1M | $138.7M | $275.8M | $340.2M | |
| Operating Income | $59.7M | $66.7M | $71.9M | $64.1M | $126.2M | |
| Net Interest Expenses | -- | -- | -- | $2.3M | -- | |
| EBT. Incl. Unusual Items | $48.9M | $70.5M | $74.7M | $47.6M | $188.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.4M | $16M | $17M | $15.8M | -$14.7M | |
| Net Income to Company | $41.5M | $54.6M | $57.7M | $31.8M | $202.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $41.5M | $54.6M | $57.7M | $31.8M | $202.8M | |
| Basic EPS (Cont. Ops) | $0.41 | $0.54 | $0.58 | $0.23 | $1.50 | |
| Diluted EPS (Cont. Ops) | $0.40 | -- | -- | -- | -- | |
| Weighted Average Basic Share | $100.4M | $100.7M | $100.4M | $135.2M | $135.2M | |
| Weighted Average Diluted Share | $103.5M | $102.9M | $101.8M | $137M | $136.5M | |
| EBITDA | $78.9M | $83.6M | $90M | $127.7M | $196.9M | |
| EBIT | $59.7M | $66.7M | $71.9M | $64.1M | $126.2M | |
| Revenue (Reported) | $251M | $263.6M | $291.6M | $629.7M | $745.3M | |
| Operating Income (Reported) | $59.7M | $66.7M | $71.9M | $64.1M | $126.2M | |
| Operating Income (Adjusted) | $59.7M | $66.7M | $71.9M | $64.1M | $126.2M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $927.9M | $973.9M | $1.1B | $2.2B | $2.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $236.8M | $266M | $301.4M | $1B | $1.1B | |
| Gross Profit | $691.1M | $707.9M | $795.6M | $1.2B | $1.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $60.1M | $67.4M | $80.5M | $163.9M | $128.9M | |
| Selling, General & Admin | $386.3M | $410.5M | $467.1M | $887.8M | $483.5M | |
| Other Inc / (Exp) | -$16.1M | -$11.1M | -$10.4M | -$101.8M | $24.2M | |
| Operating Expenses | $464.8M | $477.8M | $544.9M | $1.1B | $1.2B | |
| Operating Income | $226.3M | $230.1M | $250.7M | $181.2M | $363.1M | |
| Net Interest Expenses | -- | -- | -- | $6.8M | $775K | |
| EBT. Incl. Unusual Items | $221.5M | $193.7M | $261.4M | $66.6M | $373.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $37.4M | $38.7M | $57.1M | $25.9M | $16.9M | |
| Net Income to Company | $184M | $155M | $204.3M | $40.7M | $356.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $184M | $155M | $204.3M | $40.7M | $356.6M | |
| Basic EPS (Cont. Ops) | $1.85 | $1.53 | $2.04 | $0.30 | $2.63 | |
| Diluted EPS (Cont. Ops) | $1.80 | -- | -- | -- | -- | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $295.8M | $297.4M | $321.4M | $408.6M | $635M | |
| EBIT | $226.3M | $230.1M | $250.7M | $181.2M | $363.1M | |
| Revenue (Reported) | $927.9M | $973.9M | $1.1B | $2.2B | $2.6B | |
| Operating Income (Reported) | $226.3M | $230.1M | $250.7M | $181.2M | $363.1M | |
| Operating Income (Adjusted) | $226.3M | $230.1M | $250.7M | $181.2M | $363.1M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $478.4M | $494.2M | $568.3M | $1.2B | $1.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $118.9M | $136.5M | $156.4M | $560.9M | $503.2M | |
| Gross Profit | $359.5M | $357.7M | $411.9M | $675.4M | $840.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $30.5M | $34.8M | $42.4M | $82.4M | $72.7M | |
| Selling, General & Admin | $205.1M | $207.5M | $242.5M | $486.8M | $242.8M | |
| Other Inc / (Exp) | -$13.6M | -$963K | -$3.9M | -$49.1M | $68.6M | |
| Operating Expenses | $245M | $242.3M | $282.2M | $569.2M | $615.9M | |
| Operating Income | $114.5M | $115.4M | $129.7M | $106.3M | $224.4M | |
| Net Interest Expenses | -- | -- | -- | $4.2M | -- | |
| EBT. Incl. Unusual Items | $106.1M | $119.4M | $137.9M | $39M | $291.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.3M | $26.8M | $31M | $14.4M | $13.5M | |
| Net Income to Company | $86.9M | $92.7M | $106.8M | $24.6M | $278.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $86.9M | $92.7M | $106.8M | $24.6M | $278.3M | |
| Basic EPS (Cont. Ops) | $0.86 | $0.92 | $1.06 | $0.18 | $2.05 | |
| Diluted EPS (Cont. Ops) | $0.84 | -- | -- | -- | -- | |
| Weighted Average Basic Share | $200.3M | $202.3M | $200.7M | $270.6M | $272M | |
| Weighted Average Diluted Share | $205.9M | $207M | $204M | $272.3M | $276.3M | |
| EBITDA | $150.8M | $149.1M | $165.9M | $225.1M | $361.2M | |
| EBIT | $114.5M | $115.4M | $129.7M | $106.3M | $224.4M | |
| Revenue (Reported) | $478.4M | $494.2M | $568.3M | $1.2B | $1.3B | |
| Operating Income (Reported) | $114.5M | $115.4M | $129.7M | $106.3M | $224.4M | |
| Operating Income (Adjusted) | $114.5M | $115.4M | $129.7M | $106.3M | $224.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $239.4M | $443.4M | $446.1M | $517.8M | $890.1M | |
| Short Term Investments | $187.3M | $250.4M | $295.6M | $50.5M | $105.6M | |
| Accounts Receivable, Net | $141.7M | $164.4M | $213.2M | $503.2M | $557.7M | |
| Inventory | $229.2M | $237M | $299M | $848.1M | $659.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $17.8M | $18.4M | $21M | $44.6M | $49.6M | |
| Total Current Assets | $821.8M | $864.5M | $983.3M | $1.9B | $2.2B | |
| Property Plant And Equipment | $216.9M | $226.1M | $243.7M | $647.7M | $612.1M | |
| Long-Term Investments | $358.5M | $562.5M | $495.9M | $75.4M | $66.1M | |
| Goodwill | $156.7M | $179.7M | $197.5M | $1.4B | $1.4B | |
| Other Intangibles | $86.9M | $68.7M | $63.6M | $924.6M | $795.1M | |
| Other Long-Term Assets | $32M | $36.3M | $37.3M | $78.6M | $75.1M | |
| Total Assets | $1.7B | $2B | $2.1B | $5.1B | $5.3B | |
| Accounts Payable | $18.2M | $22M | $36.1M | $56.7M | $75.1M | |
| Accrued Expenses | $28.4M | $32.3M | $28.8M | $75.9M | $74.7M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $443.4M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $2.5M | $12M | $10.2M | |
| Other Current Liabilities | $5.8M | $11.8M | $13.3M | $61M | $33.7M | |
| Total Current Liabilities | $120.8M | $140.2M | $159.2M | $392.3M | $855.9M | |
| Long-Term Debt | -- | $2.9M | -- | $508.8M | $83.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $173.2M | $215.9M | $229.8M | $1.1B | $1.1B | |
| Common Stock | $99K | $101K | $100K | $136K | $137K | |
| Other Common Equity Adj | $4M | -$6.8M | -$24.6M | -$10.2M | -$6.9M | |
| Common Equity | $1.5B | $1.7B | $1.8B | $4B | $4.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.5B | $1.7B | $1.8B | $4B | $4.2B | |
| Total Liabilities and Equity | $1.7B | $2B | $2.1B | $5.1B | $5.3B | |
| Cash and Short Terms | $426.7M | $443.4M | $446.1M | $517.8M | $890.1M | |
| Total Debt | -- | $5.1M | -- | $521.2M | $537.7M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $268.8M | $408M | $612.8M | $492.9M | $229.4M | |
| Short Term Investments | $191.6M | $257.2M | $306.4M | $82.5M | -- | |
| Accounts Receivable, Net | $165.9M | $192.8M | $240.2M | $611.8M | $611.6M | |
| Inventory | $231.2M | $266M | $335.6M | $770.5M | $772.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $15.2M | $18.6M | $19.7M | $46.2M | $68.2M | |
| Total Current Assets | $892M | $891.2M | $1.2B | $1.9B | $1.7B | |
| Property Plant And Equipment | $210.7M | $238.9M | $248M | $627.3M | $649.4M | |
| Long-Term Investments | $453.7M | $473.7M | $391.5M | $27.8M | -- | |
| Goodwill | $155.8M | $182.7M | $198.9M | $1.5B | $1.4B | |
| Other Intangibles | $76.2M | $59.1M | $54.9M | $866.6M | $796.4M | |
| Other Long-Term Assets | $33.1M | $34M | $47.2M | $77.6M | $74.8M | |
| Total Assets | $1.8B | $1.9B | $2.2B | $5B | $5B | |
| Accounts Payable | $21.3M | $34.2M | $33.8M | $67.2M | $87.1M | |
| Accrued Expenses | $28.3M | $26.5M | $32.6M | $73.9M | $87.2M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $430.5M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | $11.1M | $13.2M | |
| Other Current Liabilities | $8.2M | $12.6M | $13.6M | $38.2M | $18.6M | |
| Total Current Liabilities | $130M | $146M | $155.2M | $794.1M | $424.7M | |
| Long-Term Debt | -- | -- | -- | $88.4M | $108.1M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $190.9M | $215.6M | $227.4M | $1B | $665.4M | |
| Common Stock | $101K | $99K | $100K | $135K | $135K | |
| Other Common Equity Adj | -$1.6M | -$25.4M | -$19.1M | -$11.9M | $10.2M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.6B | $1.7B | $2B | $4B | $4.3B | |
| Total Liabilities and Equity | $1.8B | $1.9B | $2.2B | $5B | $5B | |
| Cash and Short Terms | $460.4M | $408M | $612.8M | $492.9M | $229.4M | |
| Total Debt | -- | -- | -- | $531M | $121.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $102.3M | $149.2M | $190.2M | $122.9M | $103M | |
| Depreciation & Amoritzation | $62.9M | $69.9M | $68.3M | $144.7M | $254M | |
| Stock-Based Compensation | $27.1M | $30.6M | $32.8M | $52.7M | $54.2M | |
| Change in Accounts Receivable | $10.7M | -$25.9M | -$50.8M | -$49.9M | -$78.1M | |
| Change in Inventories | -$50.1M | -$12M | -$61.7M | -$70.3M | -$29.9M | |
| Cash From Operations | $198.8M | $276.3M | $178.5M | $243.5M | $520.6M | |
| Capital Expenditures | $63.7M | $56.9M | $74M | $78.3M | $115.4M | |
| Cash Acquisitions | -$33.5M | $34.5M | $31.4M | $296M | $17.6M | |
| Cash From Investing | -$117.3M | -$375.9M | -$110.4M | $303M | -$176.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$104.7M | -- | $144.5M | $225.6M | $85.8M | |
| Other Financing Activities | -$6.3M | -$9.3M | -$7.2M | -$18.7M | -$52.3M | |
| Cash From Financing | -$38.7M | $54.1M | -$110M | -$231.8M | -$27.7M | |
| Beginning Cash (CF) | $195.7M | $193.1M | $150.5M | $467.3M | $784.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $42.8M | -$46.3M | -$42.6M | $316.8M | $317.1M | |
| Ending Cash (CF) | $239.4M | $145.9M | $107.1M | $786.3M | $1.1B | |
| Levered Free Cash Flow | $135.1M | $219.4M | $104.4M | $165.2M | $405.2M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $41.5M | $54.6M | $57.7M | $31.8M | $202.8M | |
| Depreciation & Amoritzation | $19.1M | $16.9M | $18.1M | $63.6M | $70.6M | |
| Stock-Based Compensation | $7.6M | $7.8M | $8.6M | $12.8M | $13.6M | |
| Change in Accounts Receivable | -$5.2M | -$28.6M | -$18.4M | -$87.8M | -$2.2M | |
| Change in Inventories | -$2M | -$13.5M | -$16.2M | -$13.9M | -$4.1M | |
| Cash From Operations | $59.2M | $36.9M | $35M | $54.3M | $77.9M | |
| Capital Expenditures | $8.4M | $23.8M | $17.9M | $27.8M | $46.6M | |
| Cash Acquisitions | -- | $175K | -- | $4.9M | $252.5M | |
| Cash From Investing | -$143K | $27.1M | $52.2M | -$10.4M | -$299.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $144.5M | -- | $1.5M | $25M | |
| Other Financing Activities | -$1.6M | -$1.9M | -$2.1M | -$4.1M | -$4.6M | |
| Cash From Financing | $24.9M | -$142.8M | $1.1M | $8.7M | -$24.9M | |
| Beginning Cash (CF) | $184.8M | $150.8M | $306.5M | $410.4M | $229.4M | |
| Foreign Exchange Rate Adjustment | -$39K | -$264K | $433K | $3.8M | $14.4M | |
| Additions / Reductions | $84M | -$79M | $88.8M | $56.4M | -$231.8M | |
| Ending Cash (CF) | $268.8M | $71.5M | $395.7M | $470.6M | $12M | |
| Levered Free Cash Flow | $50.8M | $13.1M | $17.2M | $26.5M | $31.3M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $184M | $155M | $204.3M | $40.7M | $356.6M | |
| Depreciation & Amoritzation | $69.5M | $67.3M | $70.7M | $227.4M | $271.9M | |
| Stock-Based Compensation | $28.3M | $31.2M | $34.4M | $65.3M | $50.9M | |
| Change in Accounts Receivable | -$34.2M | -$30.5M | -$48.9M | -$145.9M | $66.5M | |
| Change in Inventories | -$21.8M | -$37.4M | -$69M | -$54.5M | -$18.7M | |
| Cash From Operations | $256.2M | $235.1M | $185.2M | $261.8M | $669.2M | |
| Capital Expenditures | $53.4M | $78.6M | $64.2M | $100.8M | $146.7M | |
| Cash Acquisitions | -$11.5M | $35.7M | $32.9M | $310.9M | $252.6M | |
| Cash From Investing | -$236.7M | -$237.5M | -$60.4M | $182.8M | -$286.8M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $144.5M | -- | $310.3M | $216.5M | |
| Other Financing Activities | -$8.6M | -$9.8M | -$7.7M | -$54.5M | -$23.3M | |
| Cash From Financing | $83.4M | -$115.1M | $30.8M | -$342.9M | -$581M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $102.9M | -$118M | $155.7M | $104M | -$181M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $202.7M | $156.5M | $121.1M | $161M | $522.4M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $86.9M | $92.7M | $106.8M | $24.6M | $278.3M | |
| Depreciation & Amoritzation | $36.3M | $33.8M | $36.2M | $118.8M | $136.7M | |
| Stock-Based Compensation | $15.3M | $16M | $17.5M | $30.1M | $26.8M | |
| Change in Accounts Receivable | -$25.6M | -$30.2M | -$28.2M | -$124.2M | $20.4M | |
| Change in Inventories | -$6M | -$31.4M | -$38.7M | -$22.9M | -$11.7M | |
| Cash From Operations | $122.8M | $81.6M | $88.3M | $106.6M | $255.2M | |
| Capital Expenditures | $22.1M | $43.7M | $33.9M | $56.4M | $87.7M | |
| Cash Acquisitions | -- | $1.2M | $2.7M | $17.5M | $252.5M | |
| Cash From Investing | -$125.3M | $13.2M | $63.2M | -$57M | -$167.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$450M | |
| Repurchase of Common Stock | -- | $144.5M | -- | $84.8M | $215.5M | |
| Other Financing Activities | -$3.1M | -$3.6M | -$4M | -$39.9M | -$10.8M | |
| Cash From Financing | $32.5M | -$136.7M | $4M | -$107M | -$660.3M | |
| Beginning Cash (CF) | $424.2M | $380.6M | $524.1M | $764.5M | $690.7M | |
| Foreign Exchange Rate Adjustment | -$608K | -$387K | $407K | $461K | $17.9M | |
| Additions / Reductions | $30M | -$42.3M | $156M | -$56.9M | -$555M | |
| Ending Cash (CF) | $453.6M | $337.9M | $680.5M | $708.1M | $153.6M | |
| Levered Free Cash Flow | $100.7M | $37.8M | $54.5M | $50.3M | $167.5M | |
Get GMED Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
GMED
Sector
P/E ratio
23.80x
23.65x
PEG ratio
0.03x
-0.01x
P/B ratio
1.93x
1.83x
Price / LTM sales
3.23x
1.71x
Growth Metrics
GMED
Sector
Revenue growth
18.37%
6.16%
Earnings growth
--
--
Revenue (5-year growth)
26.25%
6.58%
Earnings forecast
$0.75
-$0.21
Profitability
GMED
Sector
Profitability FY 2024
$1.4B
$5.5M
Return on invested capital
7.95%
-28.09%
Return on assets
7.13%
-25.1%
Return on equity
8.65%
-32.69%
Earnings Date
Last Earnings Date
Aug
7
Next Earnings Date
Nov
4
Estimated Next Earnings Date
Nov
6
Balance Sheet
GMED
Sector
Total cash
$229.4M
$30.4M
Short term investments
$105.6M
$26.8M
Total assets
$5.3B
$89.3M
Long term debt
$121.4M
$10M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Clarivate Stock Undervalued?
Clarivate (NYSE:CLVT) is an analytics and research business whose services…
Is Dick’s Sporting Goods Stock Undervalued?
The market still prices Dick’s Sporting Goods (NYSE: DKS) at…
Stock Ideas
Buy
61
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Alerts
Sell
30
MRVL alert for Sep 2
Marvell Technology, Inc. [MRVL] is up 1.26% over the past day.
Buy
62
ZEPP alert for Sep 2
Zepp Health Corp. [ZEPP] is up 2.84% over the past day.
Buy
78
AMBA alert for Sep 2
Ambarella, Inc. [AMBA] is down 5.15% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
